重塑瘤免疫微环境以改善基于CAR-T细胞的癌症免疫疗法
Xueting Xia1, Zongxin Yang1, Qisi Lu2,3
1The Second Clinical Medical School, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
Molecular cancer
|August 26, 2024
概括
化学抗原受体 (CAR) T细胞疗法对血液癌症有希望,但与固体瘤作斗争. 增强CAR T细胞的功能
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在治疗血液恶性瘤方面取得了显著的成功.
- 目前的CAR T细胞疗法在固体瘤治疗方面面临挑战,原因是免疫抑制性瘤微环境.
- 瘤微环境因素限制了CAR T细胞的有效性,安全性和透能力.
研究的目的:
- 探索改善CAR T细胞治疗疗效的策略,特别是对于固体瘤.
- 研究克服免疫抑制瘤微环境的方法.
- 为了增强CAR T细胞透和抗瘤作用.
主要方法:
- 汽车T细胞的结构修改.
- 结合CAR T细胞治疗与向治疗,放射治疗或化疗.
- 监测瘤微环境和CAR T细胞状态.
主要成果:
- 增强CAR T细胞透和解决免疫抑制是促进抗瘤效应的关键.
- 综合治疗策略显示出改善治疗结果的潜力.
- 监测瘤微环境和CAR T细胞状态对于策略评估至关重要.
结论:
- 优化CAR T细胞疗法需要克服固体瘤微环境的挑战.
- 战略组合疗法和CAR T细胞修饰可以增强抗瘤活性.
- 对瘤微环境动态和CAR T细胞行为的持续研究对于推进治疗至关重要.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


